TCT 1015: Cryotherapy for Vulnerable Plaque Stabilization: Preliminary Report From Polarstar: A First-In-Human Study

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker’s Bureau - Boston Scientific Corporation; Amgen